From: Isolated tricuspid valve surgery; long-term outcomes based on Tehran Heart Center data bank report
Characteristic | Implant Type | P-value | |
---|---|---|---|
Repair (n = 150) | Replacement (n = 47) | ||
Demographics | |||
Age, mean (SD) | 43.0 (13.6) | 48.8 (13.5) | 0.011 |
Gender (female), n (%) | 81 (54.0) | 31 (66.0) | 0.149 |
Body mass index, mean (SD) | 24.9 (4.4) | 24.9 (4.4) | 0.931 |
Past Medical History and Risk Factors | |||
Diabetes, n (%) | 6 (4.0) | 6 (12.8) | 0.039 |
Hyperlipidemia, n (%) | 20 (13.4) | 11 (23.4) | 0.102 |
Rheumatic valve, n (%) | 30 (20.0) | 36 (76.6) | < 0.0001 |
Atrial septal defect, n (%) | 120 (79.5) | 8 (17.0) | |
Pre-operation | |||
NYHA functional class, mean (SD) | 1.75 (0.73) | 1.98 (0.74) | |
Ejection fraction, mean (SD) | 49.74 (5.76) | 47.37 (7.83) | 0.002 |
TAPSE, mean (SD) | 21.27 (6.93) | 17.50 (7.30) | 0.005 |
RVD, mean (SD) | 44.09 (8.21) | 39.47 (8.87) | 0.003 |
PAP, mean (SD) | 39.76 (12.57) | 40.21 (12.73) | 0.452 |